A detailed history of Cerity Partners LLC transactions in Trans Medics Group, Inc. stock. As of the latest transaction made, Cerity Partners LLC holds 1,925 shares of TMDX stock, worth $221,394. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,925
Previous 2,055 6.33%
Holding current value
$221,394
Previous $275,000 21.82%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 22, 2025

SELL
$103.61 - $132.04 $13,469 - $17,165
-130 Reduced 6.33%
1,925 $215,000
Q2 2025

Aug 13, 2025

BUY
$67.67 - $143.04 $139,061 - $293,947
2,055 New
2,055 $275,000

Others Institutions Holding TMDX

About TransMedics Group, Inc.


  • Ticker TMDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 31,831,400
  • Market Cap $3.66B
  • Description
  • TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and custo...
More about TMDX
Track This Portfolio

Track Cerity Partners LLC Portfolio

Follow Cerity Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cerity Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cerity Partners LLC with notifications on news.